No, I don’t like talk of false positive false negative etc but it can still be useful to warn people about systematic biases in meta-analysis

Simon Gates writes: Something published recently that you might consider blogging: a truly terrible article in Lancet Oncology. It raises the issue of interpreting trials of similar agents and the issue of multiplicity. However, it takes a “dichotomaniac” view and so is only concerned about whether results are “significant” (=”positive”) or not, and suggests applying …